Skip to main content

Table 3 Characteristics of veterans randomized, compared with those excluded

From: Implementation of a pragmatic randomized trial of screening for chronic kidney disease to improve care among non-diabetic hypertensive veterans

 

Randomized

(N = 1819)

Excluded

(N = 193)

 

Variable

N

(%)

N

(%)

p-value

Gender

    

0.877

 Female

8

(0.4%)

1

(1%)

 

 Male

1811

(100%)

192

(99%)

 

Age

    

0.242

 26-50

169

(9%)

14

(7%)

 

 51-60

288

(16%)

22

(11%)

 

 61-70

805

(44%)

90

(47%)

 

 71-80

557

(31%)

67

(35%)

 

Race/Ethnicity

    

0.575

 White

1009

(55%)

104

(54%)

 

 Black

298

(16%)

27

(14%)

 

 Asian/Pacific Islander

150

(8%)

14

(7%)

 

 Amer. Indian

11

(1%)

1

(1%)

 

 Hispanic

92

(5%)

10

(5%)

 

 Missing

259

(14%)

37

(19%)

 

CKD

    

0.477

 No

1808

(99%)

191

(99%)

 

 Yes

11

(1%)

2

(1%)

 

Ischemic Heart Disease

317

(17%)

37

(19%)

0.545

Congestive Heart Failure (core)

108

(6%)

7

(4%)

0.189

Cardiomyopathy

29

(2%)

1

(1%)

0.241

Cerebrovascular Disease

167

(9%)

13

(7%)

0.258

Diabetes Mellitus

34

(2%)

3

(2%)

0.757

Hyperlipidemia

1163

(64%)

124

(64%)

0.931

Hypertension (common)

1794

(99%)

191

(99%)

0.698

Chronic obstructive pulmonary disease and bronchiectasis

143

(8%)

12

(6%)

0.415

Tobacco Use Disorder

496

(27%)

48

(25%)

0.476

Drug Use Disorder

288

(16%)

42

(22%)

0.034

Alcohol Use Disorders

484

(27%)

46

(24%)

0.406

Mental Health Disorders

893

(49%)

91

(47%)

0.608

Any Hypertension Meds

1288

(71%)

116

(60%)

0.002

Beta Blockers

498

(27%)

37

(19%)

0.014

Ace Inhibitors

505

(28%)

43

(22%)

0.104

Angiotensin Receptor Blockers

134

(7%)

10

(5%)

0.263

Aspirin

250

(14%)

16

(8%)

0.033

Statins

793

(44%)

63

(33%)

0.003

NSAID

333

(18%)

25

(13%)

0.064

Urine – Dipstick Prior to Screening

   

<0.0005

 Neg (<10 mg/dl)

810

(45%)

61

(32%)

 

 Trace (10-20 mg/dl

7

(0%)

0

(0%)

 

 1+ (30 mg/dl)

62

(3%)

15

(8%)

 

 2+ (100 mg/dl)

41

(2%)

6

(3%)

 

 3+ (300-500 mg/dl)

2

(0%)

2

(1%)

 

 Missing

897

(49%)

109

(56%)

 

Albumin: Creatinine Ratio Tested

172

(9%)

7

(4%)

0.007

Creatinine Tested Prior

1658

(91%)

160

(83%)

<0.0005

Creatinine (mean, SD)

1.0

(0.2)

1.0

(0.2)

0.671

Cystatin C Tested Prior

83

(5%)

7

(4%)

0.550

Systolic Blood Pressure

139(18)

 

139(18)

 

0.87

Diastolic Blood Pressure

81(11)

 

81(9)

 

0.49

  1. All Comorbidites were ascertained by the use of administrative data. Tests “prior” means done before trial started. SBP and DBP are ascertained as mean of values within 6 months prior to randomization date